Roivant Sciences
ROIV • NASDAQ
Roivant Sciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Gline, with a market cap of $20.4B.
Market Cap$20.4B
Employees908.0
CEOMatthew Gline
CountryUnited Kingdom
Healthcare
Biotechnology
Next EarningsMay 28, 2026 · in a monthQ4 2026
Financials
Roivant Sciences FAQ
Common questions about Roivant Sciences
Roivant Sciences is scheduled to report earnings for Q4 2026 on May 28, 2026. Analysts estimate revenue of $3.7M.
Roivant Sciences has approximately 908 employees.